Back
Fortune Brands Innovations Vs. Mirum Pharmaceuticals Industry Stock Comparison
Buy
54
FBIN
Fortune Brands Innovations
Last Price:
79.06
Seasonality Move:
7.72%
Buy
75
MIRM
Mirum Pharmaceuticals
Last Price:
41.98
Seasonality Move:
32.47%
Buy
54
Fortune Brands Innovations (FBIN)
is a Buy
Is Fortune Brands Innovations a Buy, Sell or Hold?
- The current Fortune Brands Innovations [FBIN] share price is $79.05. The Score for FBIN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- FBIN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $42.00. The Score for MIRM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- MIRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FBIN Stock Price Chart
What is Fortune Brands Innovations's stock price today?
-
The Fortune Brands Innovations share price today is $79.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FBIN is experiencing selling pressure, which indicates risk of future bearish movement.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $42.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing slight buying pressure.
FBIN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.26 | Sell |
| Relative Strength Index (14 RSI): | 32.78 | Sell |
| Chaikin Money Flow: | -887276 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (83.3 - 89.04) | Sell |
| Bollinger Bands (100): | (70.77 - 86.69) | Buy |
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 63.67 | Buy |
| Chaikin Money Flow: | 75051 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.64 - 40.54) | Buy |
| Bollinger Bands (100): | (36.44 - 42.04) | Buy |
FBIN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.92 | Sell |
| 20-day SMA: | 85.84 | Sell |
| 50-day SMA: | 85 | Sell |
| 200-day SMA: | 77.5 | Buy |
| 8-day EMA: | 82.57 | Sell |
| 20-day EMA: | 84.54 | Sell |
| 50-day EMA: | 83.87 | Sell |
| 200-day EMA: | 77.55 | Buy |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.42 | Buy |
| 20-day SMA: | 39.82 | Buy |
| 50-day SMA: | 39.98 | Buy |
| 200-day SMA: | 32.76 | Buy |
| 8-day EMA: | 40.7 | Buy |
| 20-day EMA: | 40.06 | Buy |
| 50-day EMA: | 39.64 | Buy |
| 200-day EMA: | 34.84 | Buy |
Fortune Brands Innovations Earnings Growth & FBIN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $0.42 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.71 per share, and an increase next year of $0.88 per share.
Fortune Brands Innovations Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mirum Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||